Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline https://financefeeds.com/gbpnzd-technical-analysis-report-25-march-2025/